Publikationen

Michaely, L. M., Schuwerk, L., Allnoch, L., Schön, K., Waltl, I., Larsen, P.-K., Pavlou, A., Prajeeth, C. K., Rimmelzwaan, G. F., Becker, S. C., Kalinke, U., Baumgärtner, W., & Gerhauser, I. (2022). Intact type I interferon receptor signaling prevents hepatocellular necrosis but not encephalitis in a dose-dependent manner in Rift Valley fever virus infected mice. International Journal of Molecular Sciences, 23(20), Article 12492. https://doi.org/10.3390/ijms232012492
Details anzeigen

Oosting, S. F., van der Veldt, A. A. M., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., Bhattacharya, A., de Wilt, F., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., Rots, N. Y., et al. (2022). Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours. The Lancet oncology, 23(7), 833–835. https://doi.org/10.1016/s1470-2045(22)00203-0
Details anzeigen

Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Saletti, G., & Rimmelzwaan, G. F. (2022). Aging and antiviral immune response: anti PD-1 treatment improves T cell function in older adults. In Junior Scientist Zoonoses Meeting 2022: program and abstracts.
Details anzeigen

Becker, T., Elbahesh, H., Reperant, L. A., Rimmelzwaan, G. F., & Osterhaus, A. D. M. E. (2021). Influenza vaccines: successes and continuing challenges. The Journal of Infectious Diseases, 224(Supplement 4), 405–S419. https://doi.org/10.1093/infdis/jiab269
Details anzeigen

Beicht, J., Kubinski, M., Gerlach, T., & Rimmelzwaan, G. F. (2021). Influenza virus-based vector vaccines agasinst tick-borne encephalitis virus (TBEV). In Stiftung Tierärztliche Hochschule Hannover (ed.), 14th Graduate School Days: 19/20 November 2021 : University of Veterinary Medicine, Institute for Pathology. Abstract book (Zoo V 16). 14th Graduate School Days, Hannover, 19.-20.11.2021. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Dai, M., Du, W., Martínez-Romero, C., Leenders, T., Wennekes, T., Rimmelzwaan, G. F., van Kuppeveld, F. J. M., Fouchier, R. A. M., Garcia-Sastre, A., de Vries, E., & de Haan, C. A. M. (2021). Analysis of the evolution of pandemic influenza A(H1N1) virus neuraminidase reveals entanglement of different phenotypic characteristics. mBio, 12(3), Article e00287–21. https://doi.org/10.1128/mbio.00287-21
Details anzeigen

Jo, W. K., Schadenhofer, A., Habierski, A., Kaiser, F. K., Saletti, G., Ganzenmueller, T., Hage, E., Haid, S., Pietschmann, T., Hansen, G., Schulz, T. F., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Ludlow, M. (2021). Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants. Proceedings of the National Academy of Sciences of the United States of America, 118(14), Article e2026558118. https://doi.org/10.1073/pnas.2026558118
Details anzeigen

Kubinski, M., Beicht, J., Gerlach, T., Volz, A., Sutter, G., & Rimmelzwaan, G. F. (2021). Tick-borne encephalistis virus: development of a vaccine approach based on modified vaccinia virus Ankara. In Stiftung Tierärztliche Hochschule Hannover (ed.), 14th Graduate School Days: 19/20 November 2021 : University of Veterinary Medicine, Institute for Pathology. Abstract book (Zoo V 06). 14th Graduate School Days, Hannover, 19.-20.11.2021. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Oosting, S. F., van der Veldt, A. A. M., GeurtsvanKessel, C. H., Fehrmann, R. S. N., van Binnendijk, R. S., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., Bhattacharya, A., van der Heiden, M., Rimmelzwaan, G. F., Kvistborg, P., Blank, C. U., Koopmans, M. P. G., Huckriede, A. L. W., van Els, C. A. C. M., et al. (2021). mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial. The Lancet oncology, 22(12), 1681–1691. https://doi.org/10.1016/s1470-2045(21)00574-x
Details anzeigen

Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Becker, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2021). Aging and options to halt declining immunity to virus infections. Frontiers in Immunology, 12, Article 681449. https://doi.org/10.3389/fimmu.2021.681449
Details anzeigen

Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Volk, H. A., Osterhaus, A., von Köckritz-Blickwede, M., & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. In 32nd Annual Meeting of the Society of Virology: abstracts (P 267).
Details anzeigen

Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Fathi, A., Addo, M. M., Volk, H. A., Osterhaus, A., Köckritz-Blickwede, M. v., & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. Journal of Virological Methods, 317, 114733. https://doi.org/10.1016/j.jviromet.2023.114733
Details anzeigen

Schweitzer, F., Schröder, L.-J., Gudi, V., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Chittappen Kandiyil, P. (2023). In vitro CNS model to study neuroinvasion and pathogenesis of tick-borne encephalitis virus. In 16th Graduate School Day: 24/25 November 2023 : abstract book (ZSN P 13). Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines, 11(4), Article 714. https://doi.org/10.3390/vaccines11040714
Details anzeigen

Wilken, L., Stelz, S., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Transient blockade of Type I Interferon signalling promotes replication of Dengue Virus strain D2Y98P in adult wild-type mice. Viruses, 15(4), Article 814. https://doi.org/10.3390/v15040814
Details anzeigen

Michaely, L. M., Schuwerk, L., Allnoch, L., Schön, K., Waltl, I., Larsen, P.-K., Pavlou, A., Prajeeth, C. K., Rimmelzwaan, G. F., Becker, S. C., Kalinke, U., Baumgärtner, W., & Gerhauser, I. (2022). Intact type I interferon receptor signaling prevents hepatocellular necrosis but not encephalitis in a dose-dependent manner in Rift Valley fever virus infected mice. International Journal of Molecular Sciences, 23(20), Article 12492. https://doi.org/10.3390/ijms232012492
Details anzeigen

Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but not from TBEV entry into the CNS. Vaccines, 9(3: 196). https://doi.org/10.3390/vaccines9030196
Details anzeigen

Kronenberg, J., Pars, K., Brieskorn, M., Prajeeth, C. K., Heckers, S., Schwenkenbecher, P., Skripuletz, T., Pul, R., Pavlou, A., & Stangel, M. (2019). Fumaric acids directly influence gene expression of neuroprotective factors in rodent microglia. International Journal of Molecular Sciences, 20(2: 325). https://doi.org/10.3390/ijms20020325
Details anzeigen

Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
Details anzeigen

Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen

Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen

Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen

Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
Details anzeigen